1 Potassium Channel Blocker Market Overview 1.1 Potassium Channel Blocker Product Overview 1.2 Potassium Channel Blocker Market Segment by Type 1.2.1 Clinical 1.2.2 Non-clinical 1.2.3 Inactive 1.3 Global Potassium Channel Blocker Market Size by Type 1.3.1 Global Potassium Channel Blocker Market Size Overview by Type (2016-2027) 1.3.2 Global Potassium Channel Blocker Historic Market Size Review by Type (2016-2021) 1.3.2.1 Global Potassium Channel Blocker Sales Breakdown in Volume by Type (2016-2021) 1.3.2.2 Global Potassium Channel Blocker Sales Breakdown in Value by Type (2016-2021) 1.3.2.3 Global Potassium Channel Blocker Average Selling Price (ASP) by Type (2016-2021) 1.3.3 Global Potassium Channel Blocker Forecasted Market Size by Type (2022-2027) 1.3.3.1 Global Potassium Channel Blocker Sales Breakdown in Volume by Type (2022-2027) 1.3.3.2 Global Potassium Channel Blocker Sales Breakdown in Value by Type (2022-2027) 1.3.3.3 Global Potassium Channel Blocker Average Selling Price (ASP) by Type (2022-2027) 1.4 Key Regions Market Size Segment by Type 1.4.1 North America Potassium Channel Blocker Sales Breakdown by Type (2016-2021) 1.4.2 Europe Potassium Channel Blocker Sales Breakdown by Type (2016-2021) 1.4.3 Asia-Pacific Potassium Channel Blocker Sales Breakdown by Type (2016-2021) 1.4.4 Latin America Potassium Channel Blocker Sales Breakdown by Type (2016-2021) 1.4.5 Middle East and Africa Potassium Channel Blocker Sales Breakdown by Type (2016-2021) 2 Global Potassium Channel Blocker Market Competition by Company 2.1 Global Top Players by Potassium Channel Blocker Sales (2016-2021) 2.2 Global Top Players by Potassium Channel Blocker Revenue (2016-2021) 2.3 Global Top Players Potassium Channel Blocker Price (2016-2021) 2.4 Global Top Manufacturers Potassium Channel Blocker Manufacturing Base Distribution, Sales Area, Product Type 2.5 Potassium Channel Blocker Market Competitive Situation and Trends 2.5.1 Potassium Channel Blocker Market Concentration Rate (2016-2021) 2.5.2 Global 5 and 10 Largest Manufacturers by Potassium Channel Blocker Sales and Revenue in 2020 2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Potassium Channel Blocker as of 2020) 2.7 Date of Key Manufacturers Enter into Potassium Channel Blocker Market 2.8 Key Manufacturers Potassium Channel Blocker Product Offered 2.9 Mergers & Acquisitions, Expansion 3 Potassium Channel Blocker Status and Outlook by Region 3.1 Global Potassium Channel Blocker Market Size and CAGR by Region: 2016 VS 2021 VS 2026 3.2 Global Potassium Channel Blocker Historic Market Size by Region 3.2.1 Global Potassium Channel Blocker Sales in Volume by Region (2016-2021) 3.2.2 Global Potassium Channel Blocker Sales in Value by Region (2016-2021) 3.2.3 Global Potassium Channel Blocker Sales (Volume & Value) Price and Gross Margin (2016-2021) 3.3 Global Potassium Channel Blocker Forecasted Market Size by Region 3.3.1 Global Potassium Channel Blocker Sales in Volume by Region (2022-2027) 3.3.2 Global Potassium Channel Blocker Sales in Value by Region (2022-2027) 3.3.3 Global Potassium Channel Blocker Sales (Volume & Value), Price and Gross Margin (2022-2027) 4 Global Potassium Channel Blocker by Application 4.1 Potassium Channel Blocker Market Segment by Application 4.1.1 Clinic 4.1.2 Hospital 4.2 Global Potassium Channel Blocker Market Size by Application 4.2.1 Global Potassium Channel Blocker Market Size Overview by Application (2016-2027) 4.2.2 Global Potassium Channel Blocker Historic Market Size Review by Application (2016-2021) 4.2.2.1 Global Potassium Channel Blocker Sales Breakdown in Volume, by Application (2016-2021) 4.2.2.2 Global Potassium Channel Blocker Sales Breakdown in Value, by Application (2016-2021) 4.2.2.3 Global Potassium Channel Blocker Average Selling Price (ASP) by Application (2016-2021) 4.2.3 Global Potassium Channel Blocker Forecasted Market Size by Application (2022-2027) 4.2.3.1 Global Potassium Channel Blocker Sales Breakdown in Volume, by Application (2022-2027) 4.2.3.2 Global Potassium Channel Blocker Sales Breakdown in Value, by Application (2022-2027) 4.2.3.3 Global Potassium Channel Blocker Average Selling Price (ASP) by Application (2022-2027) 4.3 Key Regions Market Size Segment by Application 4.3.1 North America Potassium Channel Blocker Sales Breakdown by Application (2016-2021) 4.3.2 Europe Potassium Channel Blocker Sales Breakdown by Application (2016-2021) 4.3.3 Asia-Pacific Potassium Channel Blocker Sales Breakdown by Application (2016-2021) 4.3.4 Latin America Potassium Channel Blocker Sales Breakdown by Application (2016-2021) 4.3.5 Middle East and Africa Potassium Channel Blocker Sales Breakdown by Application (2016-2021) 5 North America Potassium Channel Blocker by Country 5.1 North America Potassium Channel Blocker Historic Market Size by Country 5.1.1 North America Potassium Channel Blocker Sales in Volume by Country (2016-2021) 5.1.2 North America Potassium Channel Blocker Sales in Value by Country (2016-2021) 5.2 North America Potassium Channel Blocker Forecasted Market Size by Country 5.2.1 North America Potassium Channel Blocker Sales in Volume by Country (2022-2027) 5.2.2 North America Potassium Channel Blocker Sales in Value by Country (2022-2027) 6 Europe Potassium Channel Blocker by Country 6.1 Europe Potassium Channel Blocker Historic Market Size by Country 6.1.1 Europe Potassium Channel Blocker Sales in Volume by Country (2016-2021) 6.1.2 Europe Potassium Channel Blocker Sales in Value by Country (2016-2021) 6.2 Europe Potassium Channel Blocker Forecasted Market Size by Country 6.2.1 Europe Potassium Channel Blocker Sales in Volume by Country (2022-2027) 6.2.2 Europe Potassium Channel Blocker Sales in Value by Country (2022-2027) 7 Asia-Pacific Potassium Channel Blocker by Region 7.1 Asia-Pacific Potassium Channel Blocker Historic Market Size by Region 7.1.1 Asia-Pacific Potassium Channel Blocker Sales in Volume by Region (2016-2021) 7.1.2 Asia-Pacific Potassium Channel Blocker Sales in Value by Region (2016-2021) 7.2 Asia-Pacific Potassium Channel Blocker Forecasted Market Size by Region 7.2.1 Asia-Pacific Potassium Channel Blocker Sales in Volume by Region (2022-2027) 7.2.2 Asia-Pacific Potassium Channel Blocker Sales in Value by Region (2022-2027) 8 Latin America Potassium Channel Blocker by Country 8.1 Latin America Potassium Channel Blocker Historic Market Size by Country 8.1.1 Latin America Potassium Channel Blocker Sales in Volume by Country (2016-2021) 8.1.2 Latin America Potassium Channel Blocker Sales in Value by Country (2016-2021) 8.2 Latin America Potassium Channel Blocker Forecasted Market Size by Country 8.2.1 Latin America Potassium Channel Blocker Sales in Volume by Country (2022-2027) 8.2.2 Latin America Potassium Channel Blocker Sales in Value by Country (2022-2027) 9 Middle East and Africa Potassium Channel Blocker by Country 9.1 Middle East and Africa Potassium Channel Blocker Historic Market Size by Country 9.1.1 Middle East and Africa Potassium Channel Blocker Sales in Volume by Country (2016-2021) 9.1.2 Middle East and Africa Potassium Channel Blocker Sales in Value by Country (2016-2021) 9.2 Middle East and Africa Potassium Channel Blocker Forecasted Market Size by Country 9.2.1 Middle East and Africa Potassium Channel Blocker Sales in Volume by Country (2022-2027) 9.2.2 Middle East and Africa Potassium Channel Blocker Sales in Value by Country (2022-2027) 10 Company Profiles and Key Figures in Potassium Channel Blocker Business 10.1 Kineta 10.1.1 Kineta Corporation Information 10.1.2 Kineta Introduction and Business Overview 10.1.3 Kineta Potassium Channel Blocker Sales, Revenue and Gross Margin (2016-2021) 10.1.4 Kineta Potassium Channel Blocker Products Offered 10.1.5 Kineta Recent Development 10.2 Sevion Therapeutics 10.2.1 Sevion Therapeutics Corporation Information 10.2.2 Sevion Therapeutics Introduction and Business Overview 10.2.3 Sevion Therapeutics Potassium Channel Blocker Sales, Revenue and Gross Margin (2016-2021) 10.2.4 Kineta Potassium Channel Blocker Products Offered 10.2.5 Sevion Therapeutics Recent Development 10.3 Cono Genetix 10.3.1 Cono Genetix Corporation Information 10.3.2 Cono Genetix Introduction and Business Overview 10.3.3 Cono Genetix Potassium Channel Blocker Sales, Revenue and Gross Margin (2016-2021) 10.3.4 Cono Genetix Potassium Channel Blocker Products Offered 10.3.5 Cono Genetix Recent Development 10.4 KPI Therapeutics 10.4.1 KPI Therapeutics Corporation Information 10.4.2 KPI Therapeutics Introduction and Business Overview 10.4.3 KPI Therapeutics Potassium Channel Blocker Sales, Revenue and Gross Margin (2016-2021) 10.4.4 KPI Therapeutics Potassium Channel Blocker Products Offered 10.4.5 KPI Therapeutics Recent Development 10.5 Amgen 10.5.1 Amgen Corporation Information 10.5.2 Amgen Introduction and Business Overview 10.5.3 Amgen Potassium Channel Blocker Sales, Revenue and Gross Margin (2016-2021) 10.5.4 Amgen Potassium Channel Blocker Products Offered 10.5.5 Amgen Recent Development 10.6 Agenus bio 10.6.1 Agenus bio Corporation Information 10.6.2 Agenus bio Introduction and Business Overview 10.6.3 Agenus bio Potassium Channel Blocker Sales, Revenue and Gross Margin (2016-2021) 10.6.4 Agenus bio Potassium Channel Blocker Products Offered 10.6.5 Agenus bio Recent Development 10.7 Bristol-Myers Squibb 10.7.1 Bristol-Myers Squibb Corporation Information 10.7.2 Bristol-Myers Squibb Introduction and Business Overview 10.7.3 Bristol-Myers Squibb Potassium Channel Blocker Sales, Revenue and Gross Margin (2016-2021) 10.7.4 Bristol-Myers Squibb Potassium Channel Blocker Products Offered 10.7.5 Bristol-Myers Squibb Recent Development 10.8 Enumeral 10.8.1 Enumeral Corporation Information 10.8.2 Enumeral Introduction and Business Overview 10.8.3 Enumeral Potassium Channel Blocker Sales, Revenue and Gross Margin (2016-2021) 10.8.4 Enumeral Potassium Channel Blocker Products Offered 10.8.5 Enumeral Recent Development 10.9 F-star 10.9.1 F-star Corporation Information 10.9.2 F-star Introduction and Business Overview 10.9.3 F-star Potassium Channel Blocker Sales, Revenue and Gross Margin (2016-2021) 10.9.4 F-star Potassium Channel Blocker Products Offered 10.9.5 F-star Recent Development 10.10 GlaxoSmithKline 10.10.1 Company Basic Information, Manufacturing Base and Competitors 10.10.2 Potassium Channel Blocker Product Category, Application and Specification 10.10.3 GlaxoSmithKline Potassium Channel Blocker Sales, Revenue, Price and Gross Margin (2016-2021) 10.10.4 Main Business Overview 10.10.5 GlaxoSmithKline Recent Development 10.11 North Coast Bio 10.11.1 North Coast Bio Corporation Information 10.11.2 North Coast Bio Introduction and Business Overview 10.11.3 North Coast Bio Potassium Channel Blocker Sales, Revenue and Gross Margin (2016-2021) 10.11.4 North Coast Bio Potassium Channel Blocker Products Offered 10.11.5 North Coast Bio Recent Development 10.12 Novartis 10.12.1 Novartis Corporation Information 10.12.2 Novartis Introduction and Business Overview 10.12.3 Novartis Potassium Channel Blocker Sales, Revenue and Gross Margin (2016-2021) 10.12.4 Novartis Potassium Channel Blocker Products Offered 10.12.5 Novartis Recent Development 10.13 Regeneron 10.13.1 Regeneron Corporation Information 10.13.2 Regeneron Introduction and Business Overview 10.13.3 Regeneron Potassium Channel Blocker Sales, Revenue and Gross Margin (2016-2021) 10.13.4 Regeneron Potassium Channel Blocker Products Offered 10.13.5 Regeneron Recent Development 11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis 11.1 Potassium Channel Blocker Key Raw Materials 11.1.1 Key Raw Materials 11.1.2 Key Raw Materials Price 11.1.3 Raw Materials Key Suppliers 11.2 Manufacturing Cost Structure 11.2.1 Raw Materials 11.2.2 Labor Cost 11.2.3 Manufacturing Expenses 11.3 Potassium Channel Blocker Industrial Chain Analysis 11.4 Potassium Channel Blocker Market Dynamics 11.4.1 Industry Trends 11.4.2 Market Drivers 11.4.3 Market Challenges 11.4.4 Market Restraints 12 Market Strategy Analysis, Distributors 12.1 Sales Channel 12.2 Potassium Channel Blocker Distributors 12.3 Potassium Channel Blocker Downstream Customers 13 Research Findings and Conclusion 14 Appendix 14.1 Research Methodology 14.1.1 Methodology/Research Approach 14.1.1.1 Research Programs/Design 14.1.1.2 Market Size Estimation 14.1.1.3 Market Breakdown and Data Triangulation 14.1.2 Data Source 14.1.2.1 Secondary Sources 14.1.2.2 Primary Sources 14.2 Author Details 14.3 Disclaimer

List of Tables Table 1. Major Company of Clinical Table 2. Major Company of Non-clinical Table 3. Major Company of Inactive Table 4. Global Potassium Channel Blocker Sales by Type 2016 VS 2021 VS 2027 (US$ Million) Table 5. Global Potassium Channel Blocker Sales by Type (2016-2021) & (K MT) Table 6. Global Potassium Channel Blocker Sales Market Share in Volume by Type (2016-2021) Table 7. Global Potassium Channel Blocker Sales by Type (2016-2021) & (US& Million) Table 8. Global Potassium Channel Blocker Market Share in Value by Type (2016-2021) Table 9. Global Potassium Channel Blocker Price by Type (2016-2021) & (USD/MT) Table 10. Global Potassium Channel Blocker Sales by Type (2022-2027) & (K MT) Table 11. Global Potassium Channel Blocker Sales Market Share in Volume by Type (2022-2027) Table 12. Global Potassium Channel Blocker Sales by Type (2022-2027) & (US$ Million) Table 13. Global Potassium Channel Blocker Sales Market Share in Value by Type (2022-2027) Table 14. Global Potassium Channel Blocker Price by Type (2022-2027) & (USD/MT) Table 15. North America Potassium Channel Blocker Sales by Type (2016-2021) & (K MT) Table 16. North America Potassium Channel Blocker Sales by Type (2016-2021) & (US$ Million) Table 17. Europe Potassium Channel Blocker Sales (K MT) by Type (2016-2021) Table 18. Europe Potassium Channel Blocker Sales by Type (2016-2021) & (US$ Million) Table 19. Asia-Pacific Potassium Channel Blocker Sales (K MT) by Type (2016-2021) Table 20. Asia-Pacific Potassium Channel Blocker Sales by Type (2016-2021) & (US$ Million) Table 21. Latin America Potassium Channel Blocker Sales (K MT) by Type (2016-2021) Table 22. Latin America Potassium Channel Blocker Sales by Type (2016-2021) & (US$ Million) Table 23. Middle East and Africa Potassium Channel Blocker Sales (K MT) by Type (2016-2021) Table 24. Middle East and Africa Potassium Channel Blocker Sales by Type (2016-2021) & (US$ Million) Table 25. Global Potassium Channel Blocker Sales by Company (2016-2021) & (K MT) Table 26. Global Potassium Channel Blocker Sales Share by Company (2016-2021) Table 27. Global Potassium Channel Blocker Revenue by Company (2016-2021) & (US$ Million) Table 28. Global Potassium Channel Blocker Revenue Share by Company (2016-2021) Table 29. Global Market Potassium Channel Blocker Price by Company (2016-2021) & (USD/MT) Table 30. Global Potassium Channel Blocker Top Manufacturers Manufacturing Base Distribution and Sales Area Table 31. Global Potassium Channel Blocker Manufacturers Market Concentration Ratio (CR5 and HHI) Table 32. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Potassium Channel Blocker as of 2020 Table 33. Date of Key Manufacturers Enter into Potassium Channel Blocker Market Table 34. Key Manufacturers Potassium Channel Blocker Product Type Table 35. Mergers & Acquisitions, Expansion Plans Table 36. Global Potassium Channel Blocker Market Size Comparison by Region (US$ Million): 2016 VS 2021 VS 2027 Table 37. Global Potassium Channel Blocker Sales by Region (2016-2021) & (K MT) Table 38. Global Potassium Channel Blocker Sales Market Share in Volume by Region (2016-2021) Table 39. Global Potassium Channel Blocker Sales by Region (2016-2021) & (US$ Million) Table 40. Global Potassium Channel Blocker Sales Market Share in Value by Region (2016-2021) Table 41. Global Potassium Channel Blocker Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021) Table 42. Global Potassium Channel Blocker Sales by Region (2022-2027) & (K MT) Table 43. Global Potassium Channel Blocker Sales Market Share in Volume by Region (2022-2027) Table 44. Global Potassium Channel Blocker Sales by Region (2022-2027) & (US$ Million) Table 45. Global Potassium Channel Blocker Sales Market Share in Value by Region (2022-2027) Table 46. Global Potassium Channel Blocker Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2022-2027) Table 47. Global Potassium Channel Blocker Sales by Application: 2016 VS 2021 VS 2027 (US$ Million) Table 48. Global Potassium Channel Blocker Sales by Application (2016-2021) & (K MT) Table 49. Global Potassium Channel Blocker Sales Market Share in Volume by Application (2016-2021) Table 50. Global Potassium Channel Blocker Sales by Application (2016-2021) & (US$ Million) Table 51. Global Potassium Channel Blocker Sales Market Share in Value by Application (2016-2021) Table 52. Global Potassium Channel Blocker Price by Application (2016-2021) & (USD/MT) Table 53. Global Potassium Channel Blocker Sales by Application (2022-2027) & (K MT) Table 54. Global Potassium Channel Blocker Sales Market Share in Volume by Application (2022-2027) Table 55. Global Potassium Channel Blocker Sales by Application (2022-2027) & (US$ Million) Table 56. Global Potassium Channel Blocker Sales Market Share in Value by Application (2022-2027) Table 57. Global Potassium Channel Blocker Price by Application (2022-2027) & (USD/MT) Table 58. North America Potassium Channel Blocker Sales by Application (2016-2021) (K MT) Table 59. North America Potassium Channel Blocker Sales by Application (2016-2021) & (US$ Million) Table 60. North America Potassium Channel Blocker Sales Market Share in Value by Application in 2020 Table 61. Europe Potassium Channel Blocker Sales by Application (2016-2021) (K MT) Table 62. Europe Potassium Channel Blocker Sales by Application (2016-2021) & (US$ Million) Table 63. Europe Potassium Channel Blocker Sales Market Share in Value by Application in 2020 Table 64. Asia-Pacific Potassium Channel Blocker Sales by Application (2016-2021) (K MT) Table 65. Asia-Pacific Potassium Channel Blocker Sales by Application (2016-2021) & (US$ Million) Table 66. Asia-Pacific Potassium Channel Blocker Sales Market Share in Value by Application in 2020 Table 67. Latin America Potassium Channel Blocker Sales by Application (2016-2021) (K MT) Table 68. Latin America Potassium Channel Blocker Sales by Application (2016-2021) & (US$ Million) Table 69. Latin America Potassium Channel Blocker Sales Market Share in Value by Application in 2020 Table 70. Middle East and Africa Potassium Channel Blocker Sales by Application (2016-2021) (K MT) Table 71. Middle East and Africa Potassium Channel Blocker Sales by Application (2016-2021) & (US$ Million) Table 72. Middle East and Africa Potassium Channel Blocker Sales Market Share in Value by Application in 2020 Table 73. North America Potassium Channel Blocker Sales by Country (2016-2021) & (K MT) Table 74. North America Potassium Channel Blocker Sales Market Share in Volume by Country (2016-2021) Table 75. North America Potassium Channel Blocker Sales by Country (2016-2021) & (US$ Million) Table 76. North America Potassium Channel Blocker Sales Market Share in Value by Country (2016-2021) Table 77. North America Potassium Channel Blocker Sales by Country (2022-2027) & (K MT) Table 78. North America Potassium Channel Blocker Sales Market Share in Volume by Country (2022-2027) Table 79. North America Potassium Channel Blocker Sales by Country (2022-2027) & (US$ Million) Table 80. North America Potassium Channel Blocker Sales Market Share in Value by Country (2022-2027) Table 81. Europe Potassium Channel Blocker Sales by Country (2016-2021) & (K MT) Table 82. Europe Potassium Channel Blocker Sales Market Share in Volume by Country (2016-2021) Table 83. Europe Potassium Channel Blocker Sales by Country (2016-2021) & (US$ Million) Table 84. Europe Potassium Channel Blocker Sales Market Share in Value by Country (2016-2021) Table 85. Europe Potassium Channel Blocker Sales by Country (2022-2027) & (K MT) Table 86. Europe Potassium Channel Blocker Sales Market Share in Volume by Country (2022-2027) Table 87. Europe Potassium Channel Blocker Sales by Country (2022-2027) & (US$ Million) Table 88. Europe Potassium Channel Blocker Sales Market Share in Value by Country (2022-2027) Table 89. Asia-Pacific Potassium Channel Blocker Sales by Region (2016-2021) & (K MT) Table 90. Asia-Pacific Potassium Channel Blocker Sales Market Share in Volume by Region (2016-2021) Table 91. Asia-Pacific Potassium Channel Blocker Sales by Region (2016-2021) & (US$ Million) Table 92. Asia-Pacific Potassium Channel Blocker Sales Market Share in Value by Region (2016-2021) Table 93. Asia-Pacific Potassium Channel Blocker Sales by Region (2022-2027) & (K MT) Table 94. Asia-Pacific Potassium Channel Blocker Sales Market Share in Volume by Region (2022-2027) Table 95. Asia-Pacific Potassium Channel Blocker Sales by Region (2022-2027) & (US$ Million) Table 96. Asia-Pacific Potassium Channel Blocker Sales Market Share in Value by Region (2022-2027) Table 97. Latin America Potassium Channel Blocker Sales by Country (2016-2021) & (K MT) Table 98. Latin America Potassium Channel Blocker Sales Market Share in Volume by Country (2016-2021) Table 99. Latin America Potassium Channel Blocker Sales by Country (2016-2021) & (US$ Million) Table 100. Latin America Potassium Channel Blocker Sales Market Share in Value by Country (2016-2021) Table 101. Latin America Potassium Channel Blocker Sales by Country (2022-2027) & (K MT) Table 102. Latin America Potassium Channel Blocker Sales Market Share in Volume by Country (2022-2027) Table 103. Latin America Potassium Channel Blocker Sales by Country (2022-2027) & (US$ Million) Table 104. Latin America Potassium Channel Blocker Sales Market Share in Value by Country (2022-2027) Table 105. Middle East and Africa Potassium Channel Blocker Sales by Country (2016-2021) & (K MT) Table 106. Middle East and Africa Potassium Channel Blocker Sales Market Share in Volume by Country (2016-2021) Table 107. Middle East and Africa Potassium Channel Blocker Sales by Country (2016-2021) & (US$ Million) Table 108. Middle East and Africa Potassium Channel Blocker Sales Market Share in Value by Country (2016-2021) Table 109. Middle East and Africa Potassium Channel Blocker Sales by Country (2022-2027) & (K MT) Table 110. Middle East and Africa Potassium Channel Blocker Sales Market Share in Volume by Country (2022-2027) Table 111. Middle East and Africa Potassium Channel Blocker Sales by Country (2022-2027) & (US$ Million) Table 112. Middle East and Africa Potassium Channel Blocker Sales Market Share in Value by Country (2022-2027) Table 113. Kineta Corporation Information Table 114. Kineta Introduction and Business Overview Table 115. Kineta Potassium Channel Blocker Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021) Table 116. Kineta Potassium Channel Blocker Product Table 117. Kineta Recent Development Table 118. Sevion Therapeutics Corporation Information Table 119. Sevion Therapeutics Introduction and Business Overview Table 120. Sevion Therapeutics Potassium Channel Blocker Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021) Table 121. Sevion Therapeutics Potassium Channel Blocker Product Table 122. Sevion Therapeutics Recent Development Table 123. Cono Genetix Corporation Information Table 124. Cono Genetix Introduction and Business Overview Table 125. Cono Genetix Potassium Channel Blocker Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021) Table 126. Cono Genetix Potassium Channel Blocker Product Table 127. Cono Genetix Recent Development Table 128. KPI Therapeutics Corporation Information Table 129. KPI Therapeutics Introduction and Business Overview Table 130. KPI Therapeutics Potassium Channel Blocker Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021) Table 131. KPI Therapeutics Potassium Channel Blocker Product Table 132. KPI Therapeutics Recent Development Table 133. Amgen Corporation Information Table 134. Amgen Introduction and Business Overview Table 135. Amgen Potassium Channel Blocker Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021) Table 136. Amgen Potassium Channel Blocker Product Table 137. Amgen Recent Development Table 138. Agenus bio Corporation Information Table 139. Agenus bio Introduction and Business Overview Table 140. Agenus bio Potassium Channel Blocker Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021) Table 141. Agenus bio Potassium Channel Blocker Product Table 142. Agenus bio Recent Development Table 143. Bristol-Myers Squibb Corporation Information Table 144. Bristol-Myers Squibb Introduction and Business Overview Table 145. Bristol-Myers Squibb Potassium Channel Blocker Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021) Table 146. Bristol-Myers Squibb Potassium Channel Blocker Product Table 147. Bristol-Myers Squibb Recent Development Table 148. Enumeral Corporation Information Table 149. Enumeral Introduction and Business Overview Table 150. Enumeral Potassium Channel Blocker Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021) Table 151. Enumeral Potassium Channel Blocker Product Table 152. Enumeral Recent Development Table 153. F-star Corporation Information Table 154. F-star Introduction and Business Overview Table 155. F-star Potassium Channel Blocker Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021) Table 156. F-star Potassium Channel Blocker Product Table 157. F-star Recent Development Table 158. GlaxoSmithKline Corporation Information Table 159. GlaxoSmithKline Introduction and Business Overview Table 160. GlaxoSmithKline Potassium Channel Blocker Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021) Table 161. GlaxoSmithKline Potassium Channel Blocker Product Table 162. GlaxoSmithKline Recent Development Table 163. North Coast Bio Corporation Information Table 164. North Coast Bio Introduction and Business Overview Table 165. North Coast Bio Potassium Channel Blocker Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021) Table 166. North Coast Bio Potassium Channel Blocker Product Table 167. North Coast Bio Recent Development Table 168. Novartis Corporation Information Table 169. Novartis Introduction and Business Overview Table 170. Novartis Potassium Channel Blocker Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021) Table 171. Novartis Potassium Channel Blocker Product Table 172. Novartis Recent Development Table 173. Regeneron Corporation Information Table 174. Regeneron Introduction and Business Overview Table 175. Regeneron Potassium Channel Blocker Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021) Table 176. Regeneron Potassium Channel Blocker Product Table 177. Regeneron Recent Development Table 178. Key Raw Materials Lists Table 179. Raw Materials Key Suppliers Lists Table 180. Potassium Channel Blocker Market Trends Table 181. Potassium Channel Blocker Market Drivers Table 182. Potassium Channel Blocker Market Challenges Table 183. Potassium Channel Blocker Market Restraints Table 184. Potassium Channel Blocker Distributors List Table 185. Potassium Channel Blocker Downstream Customers Table 186. Research Programs/Design for This Report Table 187. Key Data Information from Secondary Sources Table 188. Key Data Information from Primary Sources List of Figures Figure 1. Potassium Channel Blocker Product Picture Figure 2. Global Potassium Channel Blocker Market Size, 2016 VS 2021 VS 2027 (US$ Million) Figure 3. Global Potassium Channel Blocker Market Size Status and Outlook (2016-2027) & (US$ Million) Figure 4. Global Potassium Channel Blocker Sales Status and Outlook (2016-2027) & (K MT) Figure 5. Product Picture of Clinical Figure 6. Global Clinical Sales YoY Growth (2016-2021) & (K MT) Figure 7. Product Picture of Non-clinical Figure 8. Global Non-clinical Sales YoY Growth (2016-2021) & (K MT) Figure 9. Product Picture of Inactive Figure 10. Global Inactive Sales YoY Growth (2016-2021) & (K MT) Figure 11. Global Potassium Channel Blocker Sales by Type (2016-2027) & (US$ Million) Figure 12. Global Potassium Channel Blocker Sales Market Share in Volume by Type (2016-2021) Figure 13. Global Potassium Channel Blocker Sales Market Share in Value by Type (2016-2021) Figure 14. Global Potassium Channel Blocker Sales Market Share in Volume by Type (2022-2027) Figure 15. Global Potassium Channel Blocker Sales Market Share in Value by Type (2022-2027) Figure 16. North America Potassium Channel Blocker Sales Market Share in Volume by Type in 2020 Figure 17. North America Potassium Channel Blocker Sales Market Share in Value by Type in 2020 Figure 18. Europe Potassium Channel Blocker Sales Market Share in Volume by Type in 2020 Figure 19. Europe Potassium Channel Blocker Sales Market Share in Value by Type in 2020 Figure 20. Asia-Pacific Potassium Channel Blocker Sales Market Share in Volume by Type in 2020 Figure 21. Asia-Pacific Potassium Channel Blocker Sales Market Share in Value by Type in 2020 Figure 22. Latin America Potassium Channel Blocker Sales Market Share in Volume by Type in 2020 Figure 23. Latin America Potassium Channel Blocker Sales Market Share in Value by Type in 2020 Figure 24. Middle East and Africa Potassium Channel Blocker Sales Market Share in Volume by Type in 2020 Figure 25. Middle East and Africa Potassium Channel Blocker Sales Market Share in Value by Type in 2020 Figure 26. The 5 and 10 Largest Manufacturers in the World: Market Share by Potassium Channel Blocker Sales in 2020 Figure 27. The 5 and 10 Largest Manufacturers in the World: Market Share by Potassium Channel Blocker Revenue in 2020 Figure 28. Potassium Channel Blocker Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2016 VS 2020 Figure 29. Product Picture of Clinic Figure 30. Global Clinic Sales YoY Growth (2016-2027) & (K MT) Figure 31. Product Picture of Hospital Figure 32. Global Hospital Sales YoY Growth (2016-2027) & (K MT) Figure 33. Global Potassium Channel Blocker Sales by Application (2016-2027) & (US$ Million) Figure 34. Global Potassium Channel Blocker Sales Market Share in Volume by Application (2016-2021) Figure 35. Global Potassium Channel Blocker Sales Market Share in Value by Application (2016-2021) Figure 36. Global Potassium Channel Blocker Sales Market Share in Volume by Application (2022-2027) Figure 37. North America Potassium Channel Blocker Sales Market Share in Volume by Application in 2020 Figure 38. Latin America Potassium Channel Blocker Sales Market Share in Value by Application in 2020 Figure 39. Middle East and Africa Potassium Channel Blocker Sales Market Share in Value by Application in 2020 Figure 40. Key Raw Materials Price Figure 41. Potassium Channel Blocker Manufacturing Cost Structure Figure 42. Potassium Channel Blocker Industrial Chain Analysis Figure 43. Channels of Distribution Figure 44. Distributors Profiles Figure 45. Bottom-up and Top-down Approaches for This Report Figure 46. Data Triangulation Figure 47. Key Executives Interviewed

Kineta Sevion Therapeutics Cono Genetix KPI Therapeutics Amgen Agenus bio Bristol-Myers Squibb Enumeral F-star GlaxoSmithKline North Coast Bio Novartis Regeneron